iifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

IHH Healthcare can move with open offer for Fortis only after Delhi High Court's approval, says SEBI

18 Nov 2022 , 11:03 AM

IHH Healthcare, a Malaysian company, said on Thursday that the Delhi High Court’s approval is required before moving further with its blocked open offer to buy a 26.1% market share of Fortis Healthcare.

IHH Healthcare invested new capital of Rs4,000 crore in Fortis in November 2018, acquiring a 31.17% stake.

In order to move on with its blocked open offer to buy an additional 26.1% interest in Fortis, the business is awaiting approval.

A Supreme Court decision prevented the open offer, which was initially slated to start on December 18, 2018, and end on January 1, 2019, covering a total amount of Rs3,300 crore.

In September, the Supreme Court ordered the Delhi High Court to take hiring forensic auditors into consideration in order to examine transactions made by Fortis and other related transactions.

IHH added that it would make the necessary announcements on time and reiterated its commitment to its investors and the Indian healthcare industry.

IHH Healthcare announced last week that it is prepared to move forward with its stalled open offer as soon as capital markets regulator SEBI approves it.

The legal dispute between Daiichi and the former Fortis Healthcare promoters caused the IHH-Fortis deal to fall through.

Later, the Supreme Court ruled to maintain the status quo with regard to Malvinder Singh and Shivinder Singh’s sale of controlling interests in Fortis Healthcare to IHH Healthcare and to halt IHH’s open offer for an additional 26.1% holding in Fortis.

Malvinder Singh and Shivinder Singh received six months in prison in September of this year as a result of the Supreme Court’s decision in a case involving the sale of Fortis shares to IHH Healthcare.

For feedback and suggestions, write to us at editorial@iifl.com

 

Related Tags

  • Fortis
  • IHH Healthcare
  • SEBI
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

Indian markets close on a positive note
14 Jun 2024|06:41 PM
Sensex and Nifty Surge
14 Jun 2024|06:43 PM
LIC stock price up by more than 5% today
14 Jun 2024|06:44 PM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.